CEL-SCI Corporation (CVM)
NYSEAMERICAN: CVM · Real-Time Price · USD
1.480
+0.100 (7.25%)
Aug 25, 2026, 4:00 PM EDT - Market closed
CEL-SCI Market Cap
CEL-SCI has a market cap or net worth of $26.03 million as of August 25, 2026. Its market cap has decreased by -60.27% in one year.
Market Cap
26.03M
Enterprise Value
27.40M
1-Year Change
-60.27%
Ranking
Category
Stock Price
$1.48
ChartMarket Cap Chart
Since February 10, 1992, CEL-SCI's market cap has decreased from $126.81M to $26.03M, a decrease of -79.47%. That is a compound annual growth rate of -4.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 26.03M | -41.14% |
| Dec 31, 2025 | 44.23M | 49.58% |
| Dec 31, 2024 | 29.57M | -78.25% |
| Dec 29, 2023 | 135.95M | 32.44% |
| Dec 30, 2022 | 102.65M | -66.57% |
| Dec 31, 2021 | 307.04M | -33.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enlivex | 25.70M |
| Barinthus Biotherapeutics | 25.40M |
| Atossa Therapeutics | 25.35M |
| GridAI Technologies | 25.27M |
| Niki BioSolutions | 25.21M |
| Dyadic International | 25.14M |
| Tvardi Therapeutics | 24.81M |
| Cellectar Biosciences | 24.48M |